Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome as a key driver of vascular disease
Masafumi Takahashi
Cardiovascular Research (2021) Vol. 118, Iss. 2, pp. 372-385
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 556
Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108053-108053
Open Access | Times Cited: 191
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Dobromir Dobrev, Jordi Heijman, Roddy Hiram, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 3, pp. 145-167
Open Access | Times Cited: 150
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Stefano Toldo, Antonio Abbate
Nature Reviews Cardiology (2023) Vol. 21, Iss. 4, pp. 219-237
Closed Access | Times Cited: 128
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 101
The mechanism and therapy of aortic aneurysms
Jianing Gao, Huanhuan Cao, Gaofei Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 90
Immune and inflammatory mechanisms in hypertension
Tomasz J. Guzik, Ryszard Nosalski, Pasquale Maffia, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 396-416
Closed Access | Times Cited: 85
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Péter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 159-216
Open Access | Times Cited: 84
Cigarette Smoking and Atherosclerotic Cardiovascular Disease
Mari Ishida, Chiemi Sakai, Yusuke Kobayashi, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 3, pp. 189-200
Open Access | Times Cited: 27
NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
Peter Libby
Cells (2021) Vol. 10, Iss. 4, pp. 951-951
Open Access | Times Cited: 98
Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome
Jiateng Hu, Yihong Jiang, Xiaoyu Wu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential
Andreas Zietzer, Philip Düsing, Laurine Reese, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 10, pp. 1220-1228
Open Access | Times Cited: 47
Inflammatory Mediators of Endothelial Dysfunction
Eirini Dri, Evangelos Lampas, George Lazaros, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 37
NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy
Kenta Fujimura, Tadayoshi Karasawa, Takanori Komada, et al.
Journal of Molecular and Cellular Cardiology (2023) Vol. 180, pp. 58-68
Closed Access | Times Cited: 32
Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
Nicola Potere, Antonio Abbate, Yogendra Kanthi, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 9, pp. 1245-1261
Open Access | Times Cited: 31
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 24
Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types
Qiaoxi Yang, Fatma Saaoud, Yifan Lu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 15
The role of immune system in atherosclerosis: Molecular mechanisms, controversies, and future possibilities
Tianle Zhang, Chenxu Pang, Mengxin Xu, et al.
Human Immunology (2024) Vol. 85, Iss. 2, pp. 110765-110765
Closed Access | Times Cited: 8
Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis
Zhipeng Zheng, Kaiyuan Li, Zhiyuan Yang, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 961-978
Closed Access | Times Cited: 8
Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction
Alejandra Romero, Pilar Dongil, Inés Valencia, et al.
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 284-284
Open Access | Times Cited: 35
Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: Targeting NLRP3 inflammasome/TXNIP pathway and autophagy modulation
Rehab M. El‐Sayed, Mohamed N Fawzy, Hala F. Zaki, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109711-109711
Closed Access | Times Cited: 20
Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation
Jiaxin Hu, Jiamin Xu, Xi Tan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023)
Open Access | Times Cited: 18
Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease
Abbas Shahi, Shima Afzali, Zahra Firoozi, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 3, pp. 513-532
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top